$60,000 of ELEVANCE HEALTH INC. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"No Surprises Act implementation and health care payment policy."
You can find more data on corporate lobbying on Quiver Quantitative.
ELV Insider Trading Activity
ELV insiders have traded $ELV stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ELV stock by insiders over the last 6 months:
- CHARLES MORGAN JR KENDRICK (EVP & President, Commercial) sold 3,196 shares for an estimated $910,604
- STEVEN H COLLIS purchased 3,000 shares for an estimated $869,519
- RONALD W PENCZEK (CAO & Controller) has made 0 purchases and 2 sales selling 1,900 shares for an estimated $765,958.
- ROBERT L JR DIXON sold 151 shares for an estimated $60,667
- AMY W SCHULMAN sold 26 shares for an estimated $7,475
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ELV Hedge Fund Activity
We have seen 566 institutional investors add shares of ELV stock to their portfolio, and 775 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,699,600 shares (-36.3%) from their portfolio in Q1 2026, for an estimated $785,867,058
- AMUNDI added 1,597,497 shares (+145.7%) to their portfolio in Q1 2026, for an estimated $465,039,364
- ORBIS ALLAN GRAY LTD removed 1,061,755 shares (-85.3%) from their portfolio in Q1 2026, for an estimated $309,082,189
- GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC removed 592,814 shares (-23.4%) from their portfolio in Q1 2026, for an estimated $172,571,119
- SG AMERICAS SECURITIES, LLC added 561,300 shares (+238.6%) to their portfolio in Q1 2026, for an estimated $163,397,236
- CAPITAL INTERNATIONAL INVESTORS removed 536,582 shares (-33.8%) from their portfolio in Q1 2026, for an estimated $156,201,703
- BLACKROCK, INC. removed 515,523 shares (-2.5%) from their portfolio in Q1 2026, for an estimated $150,071,322
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ELV Analyst Ratings
Wall Street analysts have issued reports on $ELV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/30/2026
- Wells Fargo issued a "Overweight" rating on 01/30/2026
To track analyst ratings and price targets for ELV, check out Quiver Quantitative's $ELV forecast page.
ELV Price Targets
Multiple analysts have issued price targets for $ELV recently. We have seen 16 analysts offer price targets for $ELV in the last 6 months, with a median target of $450.0.
Here are some recent targets:
- Ben Hendrix from RBC Capital set a target price of $439.0 on 07/09/2026
- Sarah James from Cantor Fitzgerald set a target price of $450.0 on 07/07/2026
- Lance Wilkes from Bernstein set a target price of $482.0 on 07/02/2026
- Lisa Gill from JP Morgan set a target price of $476.0 on 06/08/2026
- Ann Hynes from Mizuho set a target price of $465.0 on 06/08/2026
- Erin Wright from Morgan Stanley set a target price of $404.0 on 06/04/2026
- Kevin Fischbeck from B of A Securities set a target price of $460.0 on 06/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
